Vascular Surgery In This Issue
A N N U A L
Vascular Surgery Services
2
Surgical Indicators
2
Diagnostic Venous Unit
3
Meet Our Support Staff
3
Multidisciplinary Aortic Program
4
Pediatric Vascular Disease Program
4
Peripheral Arterial Disease Program
5
Venous Health Program
5
Cardiovascular Center
6
Livonia Vein Clinic
6
Veterans Administration
6
Residency and Fellowship Programs
7
Students
7
Other Programs
7
Vascular Surgery Research
8
Clinical Trials
9
Quality Assurance
9
Faculty Updates
10
Development
12
Your Support Makes a Difference
12
Acknowledging our Supporters
V S
12 12
ascular urgery
A section of the Department of Surgery
R E P O R T
2 0 1 2
Success for Today‌ Vision for Tomorrow Vascular Surgery at the University of Michigan Health System (UMHS) has realized significant achievements in 2012 in all areas of its core services: patient care, education, and research.
Patient Care
The majority of Vascular Surgery patient services are provided at the Cardiovascular Center (CVC) located in Ann Arbor, Michigan. We are happy to report that 95 percent of polled CVC patients said they would return for another visit. Similar high ratings extend to our satellite facility at the Livonia Vein Clinic (LVC), where polled patients reported an overall patient satisfaction rating of 96 percent. Vascular Surgery has also met the UMHS goal of seeing 80 percent of all new patients within four weeks of their referral date. Our vision is to create the best patient care experience and provide the most up-to-date and innovative vascular care possible.
Education
As a world-renowned academic center, we are proud to have under our umbrella a vascular surgery fellowship program, an integrated vascular residency program, and a research fellowship federally funded by a National Institutes of Health (NIH) sponsored T-32 training grant. In fact, we will graduate the first of the original integrated vascular residents in the country. Our highly sought-after programs continue to be competitive and attract the best and brightest candidates. Our vision
is to continue to provide outstanding clinical training for future academicians and leaders in vascular surgery. In the near future, our training program will be increasingly competency-based with simulation playing a more prominent role.
Research
In the areas of clinical and basic science research, amidst a tentative economy and uncertainty with federal sponsors, Vascular Surgery managed to maintain research operations within the Conrad Jobst Vascular Research Laboratories and at our Vascular Mechanics Laboratory receiving awards totaling more than $2.3M, which is on par with the prior year total of $2.4M. We were also able to maintain research spending at our biomedical clinics and laboratories, as well as with many research collaborators. Our Thomas Wakefield, MD vision is to Section Head improve the human condition by discovery through research on means to prevent, cure, and lessen the burden of vascular disease, and provide an arena to train future vascular surgeons and scientists. As we build on our solid foundation, Vascular Surgery looks forward to continued success and achievement.
Vascular Surgery Services As caregivers, our attention never diverts from providing the best patient care experience, which not only means achieving the best possible surgical outcomes, but also ensuring that the initial clinic visit and subsequent follow-up are conducted with a standard of excellence that represents the Michigan Difference. We are happy to report that during 2012, our clinic visits increased by 118 patients. Since our move to the CVC in 2007, the overall number of operative cases has increased from 1,114 cases to 1,426 cases in
2012, representing a compounded annual growth rate (CAGR) of 4.2 percent. With regard to the patient experience, the University of Michigan Health System measures patient satisfaction via a patient survey with questions evaluating a variety of categories. Survey results in 2012 reflected the following satisfaction ratings: scheduling (84 percent), general customer service (91 percent), quality of facility (89 percent), and pain management (85 percent). Clinic Cases 14,000
Vascular Operative Cases
12,000
10,000 8,000
2012
6,000
1,426 Cases
4,000
CAGR 4.2%
2,000 0
2007 1,114 Cases
CVC
Livonia
Total
FY10:
7,268
3,162
10,430
FY11:
8,582
3,487
12,069
FY12:
8,761
3,426
12,187
Surgical Indicators
In 2012, we began recording our complications via the Vascular Inventory Collaborative (VIC) Registry. Vascular and
venous surgical procedures and outcomes are presented below.
Arterial Procedures Procedural Indicators Freedom From Mortality Freedom From Myocardial Infarctions Freedom From AAA (Abdominal Aortic Aneurysm) Open (Mortality)
PAGE
2
Target
96%
96%
96%
Venous Procedures
Achievement Level
Procedural Indicators
Target
Achievement Level
97%
Freedom From Wounds
84-99%
97%
97%
Freedom From DVTs (Below The Knee)
95-98%
97%
97%
Freedom From EHIT (Endovenous Heat Induced Thrombus)
97%
97%
2012
VASCULAR
SURGERY
Diagnostic Vascular Unit The Diagnostic Vascular Unit (DVU) underwent significant changes in 2012, beginning with the addition of a third shift to accommodate an increase in both patient volume and requests for emergent studies. Our full-service clinical diagnostic labs perform approximately 2,100 tests every month, which includes both inpatient and outpatient procedures. In addition, the DVU continued annual screenings for both venous and arterial disease. The venous screening, which tests for deep vein thrombosis and venous insufficiency, resulted in more than 100 new patients at both the Livonia Vein Clinic (LVC) and the DVU. Thirteen of these new patients resulted in operative cases. The DVU and Peripheral Artery Disease (PAD) program offered a joint screening for peripheral arterial disease,
abdominal aortic aneurysm, and carotid disease. Of the 86 patients seen, eight were found to have disease. “Our annual arterial and venous These diagnostic screening events allow us to screenings provide us with proactive measures reach out to the community, to help identify and treat raise awareness and establish care for many vascular disease vascular diseases earlier processes that often go and with better results, undiagnosed.� as well as provide outreach services to the - Sandy Brown, MA, RDMS, RVT community. The DVU at the University Hospital, Cardiovascular Center, Domino Farms, and Briarwood received accreditation in venous, arterial, and cerebrovascular testing by the Intersocietal Accreditation Commission (IAC) Vascular Testing. This is the first all four locations have received this accreditation.
Meet Our Support Staff Our exemplary services could not have been provided had it not been for our top-quality clinic and administrative staff. Physician Assistants Schedulers OR Nursing Staff David Allis, PA-C Sharon Landers Gloria McInturff, RN Amy Ashlin-McSween, PA-C Dawn Skvarce Kelly Chiles, RN Deborah Rutherford, PA-C Ann Flaton, RN Jennifer Martz, CST Cheryl Rutan, RN Kate Tobiczyk, RN Nurse Practitioners Elaine Fellows, NP Clare Harris, NP Michele Kantola, NP Ann Luciano, NP Clinical Nurses Becky Bertha, RN Raquel Clayton, RN Bill LaForge, RN Charleen Minard, RN Susan Young, RN Administrative Staff Greer Peters - Eshkanian Sandra Martin Pam Moss Duwana Villemure 2012
VASCULAR
SURGERY
Left to right: Ann Luciano, NP; Raquel Clayton, RN; Becky Bertha, RN; Dawn Skvarce; Clare Harris, NP; Sharon Landers; Michele Kantola, NP; Susan Young, RN; Charlene Minard, RN; Elaine Fellows, NP; and William Bill LaForge, RN. PAGE
3
Multidisciplinary Aortic Program Vascular Surgery’s contribution to the Cardiovascular Center’s Multidisciplinary Aortic Program (MAP) continues to demonstrate excellence in surgical outcomes for aortic diseases. In 2012, 99 patients underwent open or endovascular aneurysm repair for complex abdominal aortic aneurysms. The 30day mortality for endovascular AAA repair was 1.4 percent, while the 30-day mortality for open AAA repair was 3.0 percent. In the area of aortic research, nine FDAregulated and two National Institutes of Health (NIH)-sponsored trials, along with two Department of Defense (DOD) contacts, were awarded during the last two years. These include the fenestrated endograft trial by Cook Medical and the NIH-sponsored Non-Invasive Treatment of Abdominal Aortic Aneurysm
Clinical Trial (N-TA3CT) for the medical management of small aneurysms. Seth Waits entered the research laboratory as the sponsored aortic Annual AAA Cases research fellow studying failure to rescue after AAA repair. 120 115 110 105
100
Not only is the MAP excelling in patient care and research, but also in sponsoring a multidisciplinary case conference. This continues to have broad attendance and further contributes to outstanding patient care. 95 90
85
2007
2008
2009
2010
2011
2012
110
98
115
100
97
99
Pediatric Vascular Disease Program Since its embryonic origin nearly three decades ago, the Pediatric Vascular Disease Program at University of Michigan has become the country’s most common destination for children in need of surgical management of occlusive or aneurysmal diseases of the abdominal aorta and its branches. The Program includes a multidisciplinary team led by vascular surgeons Dawn Coleman, MD, Jonathan Eliason, MD, and James Stanley, MD. The team partners with physicians from the specialties of interventional radiology, pediatric nephrology, intensive care, and anesthesia, as well as with nurses and social workers with broad knowledge of this group of patients. In 2006, the largest reported experience with pediatric renovascular hypertension caused by renal artery obstructions emanated from this Program. Two years later, in 2008, the world’s largest experience with childhood abdominal aortic coarctation (narrowing) was reported by this Program. In late spring 2013, the Program’s activity with extremity arterial reconstructions in preadolescent boys and girls will be presented before the Society for Vascular Surgery, and when published will represent the world’s largest reported
PAGE
4
experience with these children. The operative management of children with complex arterial disease now numbers more than 225. In the past year, 23 pediatric-aged patients underwent corrective vascular surgery. They came from Western Europe, the Middle East, and many major children’s hospitals in Canada and across the United States. The expert care of complex arterial diseases in children is an essential part of the University’s Vascular Surgery practice and has been a visible contribution to the Michigan Difference.
Left: Preoperative image of a young girl whose aorta was absent with blood flow to her kidneys and lower extremities being supplied by multiple web-like collateral vessels. Right: Postoperative image of newly constructed aorta with branches to both kidneys and the vessels going to her lower extremities.
2012
VASCULAR
SURGERY
Peripheral Arterial Disease Program The Peripheral Arterial Disease (PAD) program is a truly multidisciplinary program with representatives from Vascular Surgery, Interventional Radiology, Cardiology, and Vascular Medicine. This is the only such program in the country where cases are discussed, optimal management strategies are developed, and case management is shared across these disciplines. The program has a standardized outpatient management approach, increased access to wound care and pain management services, and coordinated efforts that have resulted in improvements in procedural complications and guideline-recommended medical therapy. Due to the dedication of our staff, under the leadership of Ann Luciano, NP, patients and referring physicians have utilized the program, and percutaneous and surgical case volume of all the participating disciplines have increased significantly. More specifically, the PAD clinic continues to meet its goals of seeing new patients within
one week of referral. Free PAD screening in September 2012 was a success and clinic satisfaction scores are Percent of Effort By Service greater than 90 percent. The PAD program has shared its care protocols, including statin use and hydration practices, with other disciplines within the hospital. PAD program staff have participated in site visits to other hospital centers in PAD Fiscal Year Stats Southeastern Michigan to share their program experiences. Quarterly PAD morbidity and mortality staff meetings are held, with all areas conducting PAD procedures or caring for PAD patients. Cardiology
34%
23%
43%
Interventional Radiology
Vascular Surgery
Venous Health Program The Venous Health Program is a multidisciplinary, centralized, patient-centered program that provides full service for the entire spectrum of a patient’s venous disease. The program features sub-specialty care, establishing a uniform treatment approach. Under the leadership of Clare Harris, NP, the Venous Health Program involves interdisciplinary faculty from Vascular Surgery, Vascular Medicine, Interventional Radiology, and the Livonia Vein Center. Venous Health Program Fiscal Year Stats
Innovative treatments include: radiofrequency ablations/laser ablations for superficial venous reflux, phlebectomies using Trivex Percent of Effort By Service technique (available in only two other sites in Michigan Cardiology 45% 17% and only 150 sites Interventional 38% Radiology nationally) for the removal Vascular Surgery of large and extensive varicose veins, pharmacomechanical thrombolysis for aggressive iliofemoral venous thrombosis, and recanalization of central veins to treat significant chronic venous insufficiency. The yearly volume of Venous Health patients continues to rise.
Note: NP: New Patient; RV: Returning Visit; H&P: Preoperative visit; POV: Post-operative visits.
2012
VASCULAR
SURGERY
PAGE
5
Cardiovascular Center Vascular Surgery is an integral part of the Cardiovascular Center, which includes 308 university physicians and scientists as active CVC members. The CVC’s clinical and research programs continued to grow in 2012. In addition to the CVC’s unmatched facilities, considerable funding for new ventures has been available for years from a transformative gift from the family of Samuel and Jean Frankel. In 2012, discussions commenced regarding a public celebration of their $50,000,000 largesse and the opportunity to name the CVC after this generous family. Vascular Surgery is proud to be part of what in future years will be known as the University of Michigan Samuel and Jean Frankel Cardiovascular Center.
Livonia Vein Clinic
The Livonia Vein Center (LVC) serves as an initial triage for the University of Michigan Venous Program and is an outpatient procedural site. Approximately 30 to 40 percent of new patient referrals to the CVC’s Venous Program come from the LVC. This past year, the LVC increased the total number of new patients seen in a single year and continues to pursue new marketing events in an effort to reach all surrounding communities. The LVC received the UMHS
Patient Satisfaction Award in spring and fall 2012 for overall patient satisfaction above 95 percent. This marks the third consecutive year in which the LVC has achieved the award. Lisa Pavone, MD, and Emily Cummings, MD, both participated in the Varisolve research study in 2012, giving them the opportunity to learn foam sclerotherapy. Future plans are to expand the LVC into the Troy/Birmingham region in 2013 with a second location. The site would be staffed with practitioners who currently operate the LVC, including Lisa Pavone, MD, and Emily Cummings, MD, as well as incremental mid-level providers. A strategic plan is currently under way, with a desire to launch the second site as early as possible. The expansion will increase demand for the Venous Program at the CVC.
Veterans Administration The Veterans Administration (VA) hospital remains a stalwart of clinical teaching for residents and fellows. Vascular Surgery’s effort is headed up by Peter Henke, MD, Guillermo Escobar, MD, and Katherine Gallagher, MD. Research activity is pending Institutional Review Boards (IRB) and patient safety information officer approval regarding the Aastrom Stem Cell trial for PAD, for which Peter Henke, MD is the local primary PAGE
6
investigator. Peter Henke, MD and John Rectenwald, MD are also co-investigators at the VA for the ATTRACT trial, a NIH-sponsored trial evaluating the role of pharmacomechanical thrombolysis versus best medical management in iliofemoral DVT. In 2012, the VA Hospital’s Vascular Surgery clinic treated 576 out-patients and 101 in-patients. The Vascular Lab saw 2,781 out-patients and 817 in-patients. 2012
VASCULAR
SURGERY
Residency and Fellowship Programs Vascular Surgery’s training programs continue to be among the most soughtafter programs in the nation, enabling us to match highly competitive trainees to our programs. Our residents and fellows continue to excel on their VSITE, SPE, and
NIH-sponsored T-32 Training Grant Fellows. Left to right: T. Shih, MD; A. Obi, MD; M. Girotti, MD; A. Gonzalez, MD.
Students Our student mentoring program is a tangible and visible sign of our absolute commitment to the future of Vascular Surgery. Thirty-five M3 students rotated into Vascular Surgery for the 2011-2012 Clerkship
American Board of Surgery’s qualifying and certifying examinations. We are proud to announce that our first integrated vascular resident, Frank Vandy, MD, will graduate in June 2013.
Vascular Surgery Residents and Fellows. Front Row (left to right): J. Rectenwald, MD (Program Director); S. Arya, MD (Fellow); F. Vandy, MD (Chief Resident); T. Wakefield, MD (Section Head). Back Row (left to right): N. Osborne, MD (Fellow); T. Chen, MD (Year 2 Resident); D. Campbell, MD (Year 3 Resident); D. Horne, MD (Year 1 Resident); and J. Knepper, MD (Year 4 Resident).
year. This program continues to stimulate student interest in Vascular Surgery. Two University of Michigan students have matched into Vascular residency programs, and one into our integrated Vascular residency program.
Other Programs In addition to scholarly instruction, Vascular Surgery sponsored the Milton E. Bryant lecture in 2012. The distinguished Robert M. Zwolak, MD, Professor of Surgery, Dartmouth Medical School, presented “The Patient-Centered Outcomes Research Institute: Legislation, Roll-out, Impact.” In partnership with the Conrad Jobst Vascular Institute in Toledo, Vascular Surgery
co-sponsored the annual Conrad Jobst Lecture, which featured a keynote address by Gregory L. Moneta, MD. His discussion, titled “The Venous Wars…Wins…Losses…Ties,” was a rousing event that sparked tremendous debate surrounding the ethics and decisions of using clinical trials for the treatment of illness.
Bryant Lecture
Greenfield Award
Conrad Jobst Annual Lecture
April 11-12, 2013
June 6, 2013
September 19-20, 2013
2012
VASCULAR
SURGERY
PAGE
7
Vascular Surgery Research Vascular Surgery Research had a strong year, with significant research endeavors and scholarly pursuits. Examples of Vascular Surgery funding opportunities include: Guillermo Escobar’s, MD, CVC McKay Research Grant to evaluate the effects of iodinated contrast dye in a rodent model, as well as in humans. Jose Diaz, MD, was awarded a CVC McKay Research Grant to study the effect of rosuvastatin in deep vein thrombosis. He also obtained funding from ATP Therapeutics to evaluate the antithrombotic efficacy of APT 402 in a venous thrombosis model. Katherine Gallagher, MD, secured funding as a recipient of the Taubman Scholar Award as well as the Wylie Research Award. Scholarly activity within Vascular Surgery Research was outstanding, with 94 peerreviewed publications, 29 presentations at international, national, and regional conferences, and 22 book chapters written by members.
facilities were instrumental in obtaining two DOD grants as well as the $411,000 Bristol Myers Squibb grant. Like labs across the country, the Conrad Jobst Vascular Research Laboratories will be challenged to obtain funding during 2013. The laboratories currently have five national funded government grants, along with one NIH-sponsored T-32 training grant.
Aortic Modeling
The Vascular Mechanics Laboratory was moved to new quarters at the NCRC where the bench-top and computer models for the experimental study of aortic dissection are assembled. The laboratory, under the direction of Ramon Berguer, MD, PhD, is working in collaboration with Juan Parodi, MD, the
Conrad Jobst Vascular Research Laboratories
April 2012 brought much-needed changes to the Conrad Jobst Vascular Research Laboratories at the University of Michigan. The entire Conrad Jobst Vascular Research Laboratory complex, consisting of seven separate but integrated units, was moved from its original location in the Medical Science Research Building II (MSRB) to the new North Campus Research Complex (NCRC). The move was under the direction of Daniel Myers, DVM, the head of the Conrad Jobst Vascular Research Laboratories. This consolidation has allowed the researchers an opportunity to better collaborate on studies and to share resources, thus containing costs. Positive changes in the Conrad Jobst Vascular Research Laboratories have been noticed by potential donors visiting the new location. These updated and expanded PAGE
8
Left: A mathematical model showing the blood flow in the distal part of an aortic dissection. Right: A model of the aorta constructed in a 3D printer.
surgeon responsible for developing the first endograft to treat aortic aneurysms. The current work is dedicated to modeling and providing the mechanical effects of a new approach (septectomy) to treat acute aortic dissection. Through a recently endowed Diethrich Professorship in Engineering and Vascular Surgery we have recruited Alberto Figueroa, PhD, who previously worked at Stanford developing a successful 3D functional and anatomical imaging map that can be generated through computerized angiographic tomography. Alberto Figueroa, PhD, is currently the head of Biomedical Engineering at King’s College in London, UK. 2012
VASCULAR
SURGERY
Clinical Trials In 2012, the ongoing challenge of obtaining IRB approval for retrospective studies was addressed. With the introduction of new eRsearch capabilities, these retrospective studies have been re-assembled into exempt studies, enabling separate and specific studies to be combined into larger, more open exempt studies. This reduces IRB approval time while maintaining the highest compliancy standards, and allows clinicians, residents, and fellows a much faster approval time for their retrospective studies. In 2012,
161 patients were enrolled in our clinical studies from the several hundred that were screened. In addition to retrospective studies, researchers from Vascular Surgery have been pioneers in the use of alternative contrast agents such as carbon dioxide (CO2) gas for safe endovascular aneurysm repair (EVAR) in patients with impaired kidney function. Well over 100 patients have had EVAR performed for AAA using CO2 as a contrast media. Data suggest it is both technically feasible and safe to use. Enrique Criado, MD, has performed more than 150 endovascular aneurysm repairs using CO2 angiography instead of nephrotoxic, conventional iodinated contrast angiography. John Rectenwald, MD, is a primary site investigator for the National Zenith Fenestrated Aortic Aneurysm trial. He is also a local co-investigator with Jonathan Eliason, MD, on the Noninvasive Treatment of AAA Intact, a NIH-sponsored multicenter trial.
CO2 aortography during placement of an endograft for aortic aneurysm repair.
Quality Assurance In October 2007, a quality improvement registry funded by Blue Cross Blue Shield of Michigan was initiated. This multi-center, multi-disciplinary outcome registry — the first of its kind in the United States — was designed to improve quality of care and outcomes. In January 2012, the BMC2 Vascular Interventional Collaborative (VIC ) program started to include open vascular procedures. The collaborative is led by Peter Henke, MD, for open surgical cases and Michael Grossman, MD, for PVI. Quarterly reports are given to individual physicians, along with departmental reports indicating outcomes for surgical procedures. Outcomes include death, infections, amputations, myocardial infarctions, and strokes. In the future, we will be participating in selecting
2012
VASCULAR
SURGERY
M2S modules as well. Currently, our venous data is being entered into a RedCap database, and outcomes from that database are reported to the CVC dashboard along with the open surgical outcomes of arterial procedures. We will be partnering with leaders in the next M2S varicose vein registry.
Left to right: Susan Blackburn, RN, MBA (Clinical Trial/Research); and Cathy Stabler, RN, BSN (Quality Assurance).
PAGE
9
Faculty Updates
Vascular Surgery Faculty. Front Row (left to right): R. Berguer, MD; T. Wakefield, MD; J. Stanley, MD; Back Row (left to right): J. Diaz, MD; J. Rectenwald, MD; E. Cummings, MD; D. Coleman, MD; J. Eliason, MD; P. Henke, MD; D. Myers, DVM MPH; K. Gallagher, MD; L. Pavone, MD; G. Escobar, MD; and E. Criado, MD.
Ramon Berguer, MD Continues as Editor, Annals of Vascular Surgery (Ann Arbor), and Annales de Chirurgie Vasculaire (Paris), and Annales de Cirugia Vascular (Barcelona) Stopped his clinical practice December 31, 2012, but continues with his strong research efforts Enrique Criado, MD Named the inaugural John R. Pfeifer Professor of Vascular Surgery Dawn Coleman, MD Started as Assistant Professor in Vascular Surgery at University of Michigan Emily Cummings, MD Became a Registered Vascular Technologist through the American Registry for Medical Diagnostic Sonography Serves as a member of the American Venous Forum Ulcer Committee and part of the Venous Ulcer Guidelines Taskforce Jose Diaz, MD Awarded Young Investigator Award at AAA Epidemiology, Genetics, & Pathophysiology Conference in Danville, PA (co-author, national meeting) Served as Course Director for international course: Basic Science in DVT. III World Symposium of Advances in Phlebology and Lymphology, BA, Argentina
PAGE
10
2012
VASCULAR
SURGERY
Jonathan Eliason, MD Named the second S. Martin Lindenauer Professor of Vascular Surgery Received a prestigious Department of Defense grant for his work on the treatment of acute aortic injury in the field Serves as Chair of the Membership Committee for the Midwestern Vascular Surgical Society Guillermo Escobar, MD Awarded the Arnold G. Coran Award for Excellence in Surgical Teaching Awarded the Peripheral Vascular Surgery Society Research Grant Awarded the University of Michigan Cardiovascular Center McKay Research Award Selected for the Young Surgeons Advisory Committee for the Society of Vascular Surgery Katherine Gallagher, MD Awarded the American Heart Association Young Investigator Award, Michigan Chapter Awarded the Wylie Scholar in Academic Vascular Surgery Award Received Society for Vascular Surgery Woman’s Leadership Grant Awarded the University of Michigan Taubman Emerging Scholar Grant and McKay Heart of a Champion Award Peter Henke, MD Named President, American Venous Forum Serves as Associate Editor of the Research Section of the Journal of Vascular Surgery. Named President, Michigan Vascular Society Daniel Myers, DVM Received American Society of Laboratory Animal Practitioners Excellence in Research Award Became member of the Frederick A. Coller Surgical Society (first veterinarian to be inducted) Received 2011 University of Michigan Endowment for Basic Sciences Teaching Award Lisa Pavone, MD Appointed to the American College of Phlebology Board John Rectenwald, MD Serves as member of the Society for Vascular Surgery Clinical Practice Council Serves as Chairman, Society for Vascular Surgery Resident & Student Outreach Committee Serves as member in the Association of Program Directors in Vascular Surgery, Education Committee James Stanley, MD Established the Stanley Professorship in Vascular Surgery Received the Founder’s Award from the Fibromuscular Dysplasia Society of America Received the Lifetime Achievement Award, Society for Vascular Surgery Continues as the Senior Associate Director Medical Arts Program, University of Michigan Medical School Thomas Wakefield, MD Named the inaugural James C. Stanley Professor of Vascular Surgery Received the 2012 Venous Research Award from the Venous Disease Coalition Named the University of Toledo School of Medicine Alumnus of the Year
2012
VASCULAR
SURGERY
PAGE
11
Development Vascular Surgery is committed to the betterment of humankind, which is made possible through ongoing philanthropic support. Our Doan, Frankel, Handleman, Lindenauer, Pfeifer, and Stanley Professorships, for example, set us apart from our peers. Endowed by generous patients, friends, and alumni who value the life-changing accomplishments of academic vascular surgeons, our Professorships provide resources and time for their holders to pursue new and often unchartered opportunities to advance medicine. Our educational programs receive ongoing support from the Bryant-Arnold, DeWeese, Greenfield, and Lindenauer funds, each established to benefit our trainees. Additional endowments enrich our community with the annual Jobst and Bryant lectures and the Berguer Lecture on Ethics, a generous donation made this year.
Thanks to philanthropic support from the Jobst and Frankel Foundations, a tremendous amount of knowledge has originated from the two laboratories carrying their names. Also, during the 2012 academic year, Edward (Ted) Diethrich, a University of Michigan undergraduate and medical student alumnus, established a new faculty position — a Professorship in Biomedical Engineering in Vascular Surgery — which will carry his name. Last but not least, our research is enriched by a generous gift from the Biardi family and Bud Stoddard. Vascular Surgery at Michigan continues to make a difference, thanks to our charitable philanthropic contributors. We are exceedingly grateful to all those who have helped us maintain our solid commitment to understanding, presenting, and treating vascular disease.
Your Support Makes a Difference University of Michigan Vascular Surgery is pleased to provide you with an annual update on our successes. Many of these would not have been possible without our generous supporters. Please help us realize
future successes by donating to Vascular Surgery. Donations may be made by calling (734) 232-6017 or online at www.giving.umich.edu/give/surgeryvascular.
Acknowledging Our Supporters Special thanks goes to Michael Mulholland, MD, Department of Surgery; Kim Eagle, MD; David Pinsky, MD; Richard
University of Michigan 2012
VASCULAR
SURGERY
Prager, MD; James Stanley, MD; and Linda Larin, Chief Administrative Officer, CVC for their ongoing support.
Cardiovascular Center, 1500 E. Medical Center Dr. Ann Arbor, MI 48109-5867 Phone: 734.936.5820
PAGE
12